scholarly journals Initial and long-term outcomes of Percutaneous Transluminal Angioplasty for central venous stenosis or occlusion in chronic hemodialysis patients: Analysis of 363 lesions in single center

2021 ◽  
pp. 009-017
Author(s):  
Horita Yuki ◽  
Namura Masanobu ◽  
Ikeda Masatoshi ◽  
Terai Hidenobu ◽  
Kimura Ryusuke ◽  
...  
Keyword(s):  
Percutaneous Transluminal Angioplasty ◽  
Hemodialysis Patients ◽  
Transluminal Angioplasty ◽  
Chronic Hemodialysis ◽  
Single Center ◽  
Long Term Outcomes ◽  
Central Venous ◽  
Central Venous Stenosis ◽  
Percutaneous Transluminal

scholarly journals HEMODIALYSIS;

2019 ◽  
Vol 26 (05) ◽  
Author(s):  
Amber Malik ◽  
Muhammad Tufail ◽  
Arz Muhammad
Keyword(s):  
Balloon Angioplasty ◽  
Percutaneous Transluminal Angioplasty ◽  
Patency Rate ◽  
Hemodialysis Patients ◽  
Transluminal Angioplasty ◽  
Central Venous ◽  
Central Venous Stenosis ◽  
Angioplasty Balloon ◽  
Venous Stenosis ◽  
Percutaneous Transluminal

Objective: To evaluate the treatment success rate of percutaneous transluminal angioplasty (balloon angioplasty) for peripheral and central venous stenosis in hemodialysis patients. Study Design: Retrospective/observational study. Place and Duration of Study: Department of Cardiology, Shaikh Zayed Hospital Lahore from 1st January 2018 to 30th June 2018. Methods: Thirteen patients of both genders presenting during from two years of hemodialysis failure and ipsilateral arm and neck swelling followed by peripheral and central venous stenosis were included in this study. Patients ages were ranging from 25 to 70 years. Patient’s detailed history including hemodialysis treatment, age, sex, socio-economic status was examined after taking informed consent from the patients. Percutaneous transluminal angioplasty (PTA) was performed at all the patients. Procedural success rate was examined. Results: There were 9 (69.23%) patients were men and rest (13.77%) were women. 5 (38.46%) patients were ages between 25 to 45 years, 6 (46.15%) patients had an ages 46 to 65 years and 2 (15.38%) patients were ages greater than 65 years. 10 (76.92%) had rural residency. 40 % patients had income >30000 PKR. Location and severity of lesions was examined as brachiocephalic vein, subclavian vein, Axillary vein, basilica, cephalic and median cubtal vein in 1,3,2,3,3 and 1 patients respectively. We determine priority patency rate in central lesion PTA was 82.7%, 62% and 38% at 3, 6 and 12 months and priority patency rate in peripheral lesions PTA was 87%, 79.5% and 67.8% at 3, 6 and 12 months. Conclusion: It is concluded that percutaneous transluminal angioplasty (balloon angioplasty) procedure for treatment of central and peripheral venous stenosis in hemodialysis patients was safe and effective with no procedural complications.

scholarly journals Percutaneous transluminal angioplasty for central venous stenosis or occlusion in hemodialysis patients

2018 ◽  
Vol 20 (1_suppl) ◽  
pp. 87-92 ◽  
Author(s):  
Yuki Horita
Keyword(s):  
Percutaneous Transluminal Angioplasty ◽  
Interventional Therapy ◽  
Transluminal Angioplasty ◽  
Radial Force ◽  
Brachiocephalic Vein ◽  
Central Venous ◽  
Central Venous Stenosis ◽  
Venous Stenosis ◽  
The Right ◽  
Percutaneous Transluminal

The objectives of central venous percutaneous transluminal angioplasty are to dilate the venous lesion and to extend the life of arteriovenous fistula for hemodialysis. It is reasonable to perform percutaneous transluminal angioplasty for central venous lesions if this interventional therapy is required to maintain stable dialysis therapy. However, the presence of large fresh thrombus at central venous lesion site represents a contraindication to percutaneous transluminal angioplasty unless the thrombus can first be removed by thrombectomy. Balloon angioplasty is a basic treatment for central venous lesion, but stent implantation is sometimes required. The self-expandable or balloon-expandable stent is chosen by the lesion location and characteristics. The lesion in subclavian vein is generally treated by self-expandable stent and right brachiocephalic vein is treated by balloon-expandable stent. The organic lesion of innominate vein with plaque is treated by self-expandable stent. Note that the innominate venous stenosis is sometimes caused by compression between the right brachiocephalic artery and the sternum, and this lesion is treated by balloon-expandable stent because the radial force of balloon-expandable stent is stronger than self-expandable stent. It is important to understand the indication and stent selection for central venous percutaneous transluminal angioplasty.

scholarly journals Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients

2007 ◽  
Vol 45 (4) ◽  
pp. 776-783 ◽  
Author(s):  
Andrew M. Bakken ◽  
Clinton D. Protack ◽  
Wael E. Saad ◽  
David E. Lee ◽  
David L. Waldman ◽  
...  
Keyword(s):  
Primary Angioplasty ◽  
Hemodialysis Patients ◽  
Long Term Outcomes ◽  
Central Venous ◽  
Central Venous Stenosis ◽  
Venous Stenosis ◽  
Primary Stenting
Sign in / Sign up

Export Citation Format

Share Document